GMO Research & AI, Inc. Logo

GMO Research & AI, Inc.

3695.T

()
Stock Price

2.480,00 JPY

8.52% ROA

11.23% ROE

19.45x PER

Market Cap.

4.367.059.191,00 JPY

0.35% DER

4.3% Yield

4.49% NPM

GMO Research & AI, Inc. Stock Analysis

GMO Research & AI, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

GMO Research & AI, Inc. Fundamental Stock Analysis
# Analysis Rating

GMO Research & AI, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

GMO Research & AI, Inc. Technical Stock Analysis
# Analysis Recommendation

GMO Research & AI, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

GMO Research & AI, Inc. Revenue
Year Revenue Growth
2019 3.290.976.000
2020 3.394.929.000 3.06%
2021 4.086.401.000 16.92%
2022 5.200.640.000 21.43%
2023 5.117.203.000 -1.63%
2024 4.412.904.000 -15.96%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

GMO Research & AI, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2019 0
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

GMO Research & AI, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2019 0
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

GMO Research & AI, Inc. EBITDA
Year EBITDA Growth
2019 300.313.000
2020 315.473.000 4.81%
2021 452.849.000 30.34%
2022 551.256.000 17.85%
2023 530.861.000 -3.84%
2024 -93.184.000 669.69%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

GMO Research & AI, Inc. Gross Profit
Year Gross Profit Growth
2019 1.601.428.000
2020 1.585.734.000 -0.99%
2021 1.980.288.000 19.92%
2022 2.463.698.000 19.62%
2023 2.542.373.000 3.09%
2024 2.050.548.000 -23.99%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

GMO Research & AI, Inc. Net Profit
Year Net Profit Growth
2019 137.346.000
2020 175.672.000 21.82%
2021 274.065.000 35.9%
2022 356.385.000 23.1%
2023 307.314.000 -15.97%
2024 -80.328.000 482.57%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

GMO Research & AI, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2019 84
2020 108 22.43%
2021 168 36.31%
2022 218 22.94%
2023 188 -15.96%
2024 -49 483.67%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

GMO Research & AI, Inc. Free Cashflow
Year Free Cashflow Growth
2019 146.000.000
2020 268.052.000 45.53%
2021 406.933.000 34.13%
2022 39.819.000 -921.96%
2023 354.532.000 88.77%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

GMO Research & AI, Inc. Operating Cashflow
Year Operating Cashflow Growth
2019 147.000.000
2020 363.002.000 59.5%
2021 482.160.000 24.71%
2022 131.652.000 -266.24%
2023 475.490.000 72.31%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

GMO Research & AI, Inc. Capital Expenditure
Year Capital Expenditure Growth
2019 1.000.000
2020 94.950.000 98.95%
2021 75.227.000 -26.22%
2022 91.833.000 18.08%
2023 120.958.000 24.08%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

GMO Research & AI, Inc. Equity
Year Equity Growth
2019 1.378.475.000
2020 1.483.144.000 7.06%
2021 1.676.748.000 11.55%
2022 1.908.905.000 12.16%
2023 2.047.415.000 6.77%
2024 1.994.937.000 -2.63%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

GMO Research & AI, Inc. Assets
Year Assets Growth
2019 2.084.150.000
2020 2.231.647.000 6.61%
2021 2.799.835.000 20.29%
2022 3.072.220.000 8.87%
2023 2.993.556.000 -2.63%
2024 2.940.091.000 -1.82%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

GMO Research & AI, Inc. Liabilities
Year Liabilities Growth
2019 705.673.000
2020 748.503.000 5.72%
2021 1.123.087.000 33.35%
2022 1.163.315.000 3.46%
2023 946.141.000 -22.95%
2024 945.153.000 -0.1%

GMO Research & AI, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
3060.63
Net Income per Share
137.46
Price to Earning Ratio
19.45x
Price To Sales Ratio
0.87x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
2.19
EV to Sales
0.6
EV Over EBITDA
9.66
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0.05
FreeCashFlow Yield
0
Market Cap
4,37 Bil.
Enterprise Value
3,02 Bil.
Graham Number
1941.23
Graham NetNet
867.14

Income Statement Metrics

Net Income per Share
137.46
Income Quality
0
ROE
0.11
Return On Assets
0.08
Return On Capital Employed
0.15
Net Income per EBT
0.76
EBT Per Ebit
0.96
Ebit per Revenue
0.06
Effective Tax Rate
0.23

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.5
Operating Profit Margin
0.06
Pretax Profit Margin
0.06
Net Profit Margin
0.04

Dividends

Dividend Yield
0.04
Dividend Yield %
4.3
Payout Ratio
0
Dividend Per Share
114.84

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.12
Return on Tangible Assets
0.09
Days Sales Outstanding
55.1
Days Payables Outstanding
34.42
Days of Inventory on Hand
10.81
Receivables Turnover
6.62
Payables Turnover
10.6
Inventory Turnover
33.75
Capex per Share
0

Balance Sheet

Cash per Share
1.076,48
Book Value per Share
1.221,07
Tangible Book Value per Share
1034.84
Shareholders Equity per Share
1218.42
Interest Debt per Share
4.65
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-4.33
Current Ratio
2.51
Tangible Asset Value
1,69 Bil.
Net Current Asset Value
1,39 Bil.
Invested Capital
1722768000
Working Capital
1,40 Bil.
Intangibles to Total Assets
0.1
Average Receivables
1,14 Bil.
Average Payables
0,25 Bil.
Average Inventory
64234500
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

GMO Research & AI, Inc. Dividends
Year Dividends Growth
2014 37
2015 22 -63.64%
2016 24 4.35%
2017 63 62.9%
2018 45 -40.91%
2019 42 -4.76%
2020 47 8.7%
2021 84 44.58%
2022 109 23.85%
2023 115 4.39%
2024 0 0%

GMO Research & AI, Inc. Profile

About GMO Research & AI, Inc.

GMO Research & AI, Inc. provides an audience engagement platform in Japan and internationally. The company's audience engagement platform provides access to Asia Cloud Panel, a multi-panel and multi-country online panel network. The company provides quick and custom survey services. It also provides automated and agile data collection management solutions. The company was formerly known as GMO Research, Inc. and changed its name to GMO Research & AI, Inc. in May 2024. GMO Research & AI, Inc. was incorporated in 2002 and is headquartered in Tokyo, Japan. GMO Research & AI, Inc. is a subsidiary of GMO internet group, Inc.

CEO
Mr. Shinichi Hosokawa
Employee
140
Address
Cerulean Tower
Tokyo, 150-8512

GMO Research & AI, Inc. Executives & BODs

GMO Research & AI, Inc. Executives & BODs
# Name Age
1 Mr. Takenori Mori
MD, Chief Financial Officer, GM of Global Business Management HeadQuarter & Director
70
2 Mr. Tetsuya Hongo
Senior MD of Business Development Headquarters & Innovation HQ, Chief Operating Officer & Director
70
3 Mr. Yukiya Nagata
Chief Revenue Officer, MD & Director
70
4 Mr. Kenichiro Ando
GM of Global System Division, Chief Technology Officer & Director
70
5 Mr. Shinichi Hosokawa
Chief Executive Officer, President & Director
70

GMO Research & AI, Inc. Competitors